Onconetix, Inc. (ONCO)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20261 patent granted to the name below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Onconetix, Inc.’s names, not what it holds today.
3 published
| Granted | Patent | Title | Field | Owner as printed |
|---|---|---|---|---|
| May 3, 2022 | 11,320,435 | Method of detecting proteins in human samples and uses of such methods | Analysis of biological materials | ProteoMedix AG |
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Oct 10, 2024 | 2024/0337659 | METHOD OF DETECTING PROTEINS IN HUMAN SAMPLES AND USES OF SUCH METHODS | Analysis of biological materials | ProteoMedix AG |
| Aug 29, 2024 | 2024/0288433 | COMBINED METHOD OF DETECTING PROTEINS IN HUMAN SAMPLES AND MPMRI DATA | Analysis of biological materials | ProteoMedix AG |
| Aug 15, 2019 | 2019/0250163 | METHOD OF DETECTING PROTEINS IN HUMAN SAMPLES AND USES OF SUCH METHODS | Analysis of biological materials | ProteoMedix AG · patent 11,320,435 granted from it |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.